about
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialEffect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsTreating and preventing influenza in aged care facilities: a cluster randomised controlled trialPsychosocial Outcomes in StrokE: the POISE observational stroke study protocol.Thrombolysis in acute ischaemic stroke: a guide to patient selection.Improving community ambulation after stroke: the AMBULATE Trial.Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials.Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.Planning trials in older patients with stroke: data from the International Stroke Trial.Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruitedReturning to paid employment after stroke: the Psychosocial Outcomes In StrokE (POISE) cohort study.Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study.The speed of ultraearly hematoma growth in acute intracerebral hemorrhageTargeting recombinant tissue-type plasminogen activator in acute ischemic stroke based on risk of intracranial hemorrhage or poor functional outcome: an analysis of the third international stroke trialEffect of alteplase within 6 hours of acute ischemic stroke on all-cause mortality (third International Stroke Trial).Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke TrialAre rehabilitation services following stroke accessed equitably in Australia?: findings from the psychosocial outcomes in stroke (POISE) cohort study.Sensitivity and specificity of the hyperdense artery sign for arterial obstruction in acute ischemic stroke.A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties.Head Position in Stroke Trial (HeadPoST)--sitting-up vs lying-flat positioning of patients with acute stroke: study protocol for a cluster randomised controlled trialExploring threats to generalisability in a large international rehabilitation trial (AVERT).AVERT2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff.Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke.Barricades and brickwalls--a qualitative study exploring perceptions of medication use and deprescribing in long-term care.Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).Risk of Stroke in Patients with ESRDEffects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 TrialsFactors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden.Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial.Family-led rehabilitation after stroke in India: the ATTEND trial, study protocol for a randomized controlled trialCommunity-based InterVentions to prevent serIous Complications (CIVIC) following spinal cord injury in Bangladesh: protocol of a randomised controlled trial6-PACK programme to decrease fall injuries in acute hospitals: cluster randomised controlled trialThird international stroke trial (IST-3) of thrombolysis for acute ischaemic strokeHealth coaching and pedometers to enhance physical activity and prevent falls in community-dwelling people aged 60 years and over: study protocol for the Coaching for Healthy AGEing (CHAnGE) cluster randomised controlled trial.Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction.Effect of affordable technology on physical activity levels and mobility outcomes in rehabilitation: a protocol for the Activity and MObility UsiNg Technology (AMOUNT) rehabilitation trial.Protocol for process evaluation of a randomised controlled trial of family-led rehabilitation post stroke (ATTEND) in India.
P50
Q24595579-A9DC6063-1389-495C-BDC8-88617E0A5F26Q26823902-72B1E716-9051-4A25-8653-BBDCF55666FDQ28484471-2B23D943-70A7-493C-9E7B-81450392D83CQ30865390-E37D5B54-B886-48EF-82E4-923C3EFDF808Q33217342-4E58C1B6-E91D-4057-A5AF-3C63EDBAC8ECQ33408051-E4738439-BF99-4286-BCAF-B2DCEAEFADB3Q33590391-794D5D40-D607-4AA3-AB50-119F79482E2BQ33593063-C17A540A-FD66-4A9B-BDB6-E046DF951F03Q33857355-D3AA543F-BA7C-413A-84D7-7DD384B1AFA0Q33932122-337878D0-E99C-4908-9830-54BAB7125F30Q34086851-AC497634-EF60-4BD4-BA39-F37754F00ECAQ34359055-C004B007-327D-462B-B655-0F1B39097D3CQ34365689-1CC4C435-AAB6-400D-A409-DEFE3F9A5904Q34777897-AA7E1EED-56A0-40C8-8206-5BC8A1A3E4FCQ34803876-5AADC222-8142-4D40-A1F7-6AE69219ECF5Q34803882-799F46BA-A725-4B28-B521-06B42D3B64CEQ34965049-DD0CCE23-0ECD-4C7B-A75C-718587C3156BQ34996388-8B6954A8-F9C6-44EE-88E0-EB67DB011575Q35114217-B5FCCDAE-5C62-4777-83CE-4006D0B53BA5Q35156164-9BE4F699-E067-4CAA-9F4C-75D035516CEEQ35484672-B7F05997-B6A1-4E51-8A16-53A1AAE4E534Q35700659-8C490A29-FD6B-45EA-BF14-0E0F2E0904F8Q35748493-64F0F94E-43B4-473B-A7EC-54AF14204FF4Q35866720-13CEA423-60B1-435F-8AB7-9B6CC61A560DQ35867071-BBC85610-FEF9-4386-B46D-3038E099E244Q35877891-A351B2DC-5D1A-43A6-86A5-79D05A864627Q35894338-290F125B-179C-481A-AF69-26EAAC74EF31Q35926918-E5D9BD02-15B4-4F63-820A-AFCB84B8CDBEQ36025660-D1E30E11-2C84-4247-81D3-2F260AE4AE35Q36099907-478F6913-3ED4-43F3-809A-9B563A0B7935Q36183123-FEF2BA57-DFB4-482A-B742-03C1D97F270AQ36313426-C6EA4769-A36C-4598-AB2A-AD02CBA1BD1EQ36439712-EF52079B-9963-4F91-8CFE-4C569714359DQ36472205-C1C6D0F7-4AFE-4FB8-8655-9429C325464CQ36502846-DE69E7A8-607D-4054-855F-E38F02D27A44Q36742130-1F591F2D-F449-4159-A323-F628267F72D7Q36920357-0B53B712-521C-4CE8-BA5C-F556E1278A36Q36955000-70DD2C25-C103-45FE-AE87-D873B7D84634Q37007321-232854E5-71D7-499B-AEB3-06D2EDFAA51FQ37271567-FFAD9C6A-6831-4CDF-892D-3A328731ABDB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Richard I Lindley
@ast
Richard I Lindley
@en
Richard I Lindley
@es
Richard I Lindley
@nl
Richard I Lindley
@sl
type
label
Richard I Lindley
@ast
Richard I Lindley
@en
Richard I Lindley
@es
Richard I Lindley
@nl
Richard I Lindley
@sl
altLabel
Richard Lindley
@en
prefLabel
Richard I Lindley
@ast
Richard I Lindley
@en
Richard I Lindley
@es
Richard I Lindley
@nl
Richard I Lindley
@sl
P1053
B-8148-2013
P106
P21
P31
P3829
P496
0000-0002-0104-5679